Stock Earnings

Question 1

What are YiChang HEC ChangJiang Pharmaceutical Co Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), YiChang HEC ChangJiang Pharmaceutical Co Ltd has a total asset of $12,429, Net profit of $482

Question 2

What are the key financial ratios for YIHCF?

Accepted Answer

YiChang HEC ChangJiang Pharmaceutical Co Ltd's Current ratio is 3.16, has a Net margin is 12.94, sales per share of $4.23.

Question 3

How is YiChang HEC ChangJiang Pharmaceutical Co Ltd's revenue broken down by segment or geography?

Accepted Answer

YiChang HEC ChangJiang Pharmaceutical Co Ltd largest revenue segment is Anti-viral Drugs, at a revenue of 2,802,256,874 in the most earnings release.For geography, China is the primary market for YiChang HEC ChangJiang Pharmaceutical Co Ltd, at a revenue of 4,037,414,486.

Question 4

Is YiChang HEC ChangJiang Pharmaceutical Co Ltd profitable?

Accepted Answer

yes, according to the latest financial statements, YiChang HEC ChangJiang Pharmaceutical Co Ltd has a net profit of $482

Question 5

Does YiChang HEC ChangJiang Pharmaceutical Co Ltd have any liabilities?

Accepted Answer

yes, YiChang HEC ChangJiang Pharmaceutical Co Ltd has liability of 3,921

Question 6

How many outstanding shares for YiChang HEC ChangJiang Pharmaceutical Co Ltd?

Accepted Answer

YiChang HEC ChangJiang Pharmaceutical Co Ltd has a total outstanding shares of 879.96

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3,723	3,723	6,294	3,744	913	2,348
Revenue Growth (YoY)	-41%	-41%	68%	310%	-61%	-62%
Cost of Revenue	929	929	1,308	898	430	351
Gross Profit	2,794	2,794	4,985	2,846	483	1,996
Selling, General & Admin	1,657	1,657	1,939	1,551	883	1,560
Research & Development	493	493	192	129	109	--
Operating Expenses	2,125	2,125	2,115	1,663	927	1,294
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	577	577	2,126	39	-667	1,010
Income Tax Expense	94	94	270	-9	-79	173
Net Income	482	482	1,992	76	-587	839
Net Income Growth	-76%	-76%	2,521%	-112.99%	-170%	-56%
Shares Outstanding (Diluted)	879.96	879.96	879.96	879.96	879.96	1,105.75
Shares Change (YoY)	0%	0%	0%	0%	-20%	9%
EPS (Diluted)	0.54	0.54	2.26	0.08	-0.66	0.75
EPS Growth	-76%	-76%	2,500%	-112.99%	-189%	-60%
Free Cash Flow	-1,092	-1,092	1,078	846	-1,242	-618
Free Cash Flow Per Share	-1.24	-1.24	1.22	0.96	-1.41	-0.55
Gross Margin	75.04%	75.04%	79.2%	76.01%	52.9%	85%
Operating Margin	17.94%	17.94%	45.58%	31.57%	-48.52%	29.89%
Profit Margin	12.94%	12.94%	31.64%	2.02%	-64.29%	35.73%
Free Cash Flow Margin	-29.33%	-29.33%	17.12%	22.59%	-136.03%	-26.32%
EBITDA	--	1,063	3,260	1,559	-184	824
EBITDA Margin	--	28.55%	51.79%	41.63%	-20.15%	35.09%
D&A For EBITDA	--	395	391	377	259	122
EBIT	668	668	2,869	1,182	-443	702
EBIT Margin	17.94%	17.94%	45.58%	31.57%	-48.52%	29.89%
Effective Tax Rate	16.29%	16.29%	12.69%	-23.07%	11.84%	17.12%

YiChang HEC ChangJiang Pharmaceutical Co Ltd (YIHCF) Price

YIHCF Stock Price Chart

YIHCF Income

Follow-Up Questions